MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ — Telix Prescription drugs Restricted (ASX: TLX, NASDAQ: TLX, Telix, the Firm) in the present day publicizes that’s has appointed Dr. Paul Schaffer to the newly created position of Chief Know-how Officer (CTO), efficient in the present day.
(PRNewsfoto/Telix Prescription drugs Restricted)
Dr. Schaffer has been CTO at ARTMS Inc. (ARTMS) (acquired by Telix in 2024) for the previous seven years, in addition to Director, Life Science at TRIUMF, Canada’s particle accelerator analysis centre, since 2012. Primarily based in Vancouver, Canada, Dr. Schaffer is widely known for his position within the buildout and transformation of the TRIUMF Life Sciences program, which included design and building of a serious multi-cyclotron radiochemistry facility and the event of the ARTMS QUANTM Irradiation System® (QIS®) for large-scale isotope manufacturing, which was commercialized and later acquired by Telix.
As Telix CTO, Dr. Schaffer will likely be chargeable for harnessing the facility of know-how to advance Telix’s capabilities in radiopharmaceutical analysis, growth, and medical purposes. Dr. Schaffer will cowl areas together with chemistry, physics, synthetic intelligence (AI), dosimetry, and information analytics, complementing the work of Telix’s Chief Scientist, Dr. Michael Wheatcroft, and his workforce in driving cutting-edge analysis and growth (R&D).
Dr. Schaffer mentioned, “I am excited to be taking over this position at such a pivotal time for Telix, because the Firm advances quickly towards its mission of reworking affected person care. Telix has a daring dedication to innovation, and I am thrilled to collaborate with this gifted workforce to assist drive R&D for the applied sciences behind the subsequent technology of radiotherapeutics.”
Dr. Christian Behrenbruch, Telix Managing Director and Group Chief Govt Workplace, mentioned, “Paul has a formidable observe document of driving innovation in life sciences know-how, together with his groundbreaking work in large-scale isotope manufacturing. I’ve first-hand expertise of Paul’s spectacular mind, concepts and fervour by way of his work at TRIUMF and with ARTMS, so it’s a nice pleasure to have him be part of the broader Telix workforce as we proceed to steer radiopharmaceutical innovation.”
About Telix Prescription drugs Restricted
Telix is a biopharmaceutical firm targeted on the event and commercialization of therapeutic and diagnostic radiopharmaceuticals and related medical applied sciences. Telix is headquartered in Melbourne, Australia, with worldwide operations in the US, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is creating a portfolio of medical and business stage merchandise that goals to handle important unmet medical wants in oncology and uncommon illnesses. ARTMS, IsoTherapeutics, Lightpoint, Optimum Tracers and RLS are Telix Group firms. Telix is listed on the Australian Securities Change (ASX: TLX) and the Nasdaq International Choose Market (NASDAQ: TLX).
Go to www.telixpharma.com for additional details about Telix, together with particulars of the newest share value, ASX and SEC filings, investor and analyst displays, information releases, occasion particulars and different publications which may be of curiosity. You can even observe Telix on LinkedIn, X and Facebook.
Telix Investor Relations Ms. Kyahn Williamson Telix Prescription drugs Restricted SVP Investor Relations and Company Communications E mail: kyahn.williamson@telixpharma.com
Authorized Notices
It is best to learn this announcement along with our danger elements, as disclosed in our most lately filed stories with the Australian Securities Change (ASX), U.S. Securities and Change Fee (SEC), together with our Annual Report on Kind 20-F filed with the SEC, or on our web site.
The knowledge contained on this announcement isn’t meant to be a suggestion for subscription, invitation or suggestion with respect to securities of Telix Prescription drugs Restricted (Telix) in any jurisdiction, together with the US. The knowledge and opinions contained on this announcement are topic to alter with out notification. To the utmost extent permitted by legislation, Telix disclaims any obligation or enterprise to replace or revise any info or opinions contained on this announcement, together with any forward-looking statements (as referred to under), whether or not on account of new info, future developments, a change in expectations or assumptions, or in any other case. No illustration or guarantee, categorical or implied, is made in relation to the accuracy or completeness of the knowledge contained or opinions expressed in the middle of this announcement.
This announcement might comprise forward-looking statements, together with inside the that means of the U.S. Personal Securities Litigation Reform Act of 1995, that relate to anticipated future occasions, monetary efficiency, plans, methods or enterprise developments. Ahead-looking statements can usually be recognized by means of phrases akin to “might”, “anticipate”, “intend”, “plan”, “estimate”, “anticipate”, “imagine”, “outlook”, “forecast” and “steering”, or the adverse of those phrases or different related phrases or expressions. Ahead-looking statements contain identified and unknown dangers, uncertainties and different elements which will trigger our precise outcomes, ranges of exercise, efficiency or achievements to vary materially from any future outcomes, ranges of exercise, efficiency or achievements expressed or implied by these forward-looking statements. Ahead-looking statements are based mostly on Telix’s good-faith assumptions as to the monetary, market, regulatory and different dangers and issues that exist and have an effect on Telix’s enterprise and operations sooner or later and there could be no assurance that any of the assumptions will show to be appropriate. Within the context of Telix’s enterprise, forward-looking statements might embrace, however should not restricted to, statements about: the initiation, timing, progress and outcomes of Telix’s preclinical and medical trials, and Telix’s analysis and growth packages; Telix’s skill to advance product candidates into, enrol and efficiently full, medical research, together with multi-national medical trials; the timing or chance of regulatory filings and approvals for Telix’s product candidates, manufacturing actions and product advertising actions; Telix’s gross sales, advertising and distribution and manufacturing capabilities and techniques; the commercialisation of Telix’s product candidates, if or once they have been permitted; Telix’s skill to acquire an ample provide of uncooked supplies at affordable prices for its merchandise and product candidates; estimates of Telix’s bills, future revenues and capital necessities; Telix’s monetary efficiency; developments referring to Telix’s rivals and trade; and the pricing and reimbursement of Telix’s product candidates, if and after they’ve been permitted. Telix’s precise outcomes, efficiency or achievements could also be materially totally different from these which can be expressed or implied by such statements, and the variations could also be antagonistic. Accordingly, you shouldn’t place undue reliance on these forward-looking statements.
